Please Wait
Applying Filters...
menu
    • menu
    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    An Enquiry

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Sulopenem

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    US FDA approves Iterum's treatment for urinary infection
    US FDA approves Iterum's treatment for urinary infection

    26 Oct 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-iterums-treatment-urinary-infection-2024-10-25/

    REUTERS
    26 Oct 2024
    Share Share
    Iterum Announces Positive Topline Results from Phase 3 Trial of Oral Sulopenem
    Iterum Announces Positive Topline Results from Phase 3 Trial of Oral Sulopenem

    30 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/iterum-therapeutics-announces-positive-topline-results-from-its-phase-3-reassure-clinical-trial-of-oral-sulopenem-in-uncomplicated-urinary-tract-infections-302047483.html

    PR NEWSWIRE
    30 Jan 2024
    Share Share
    FDA said no in July, so Iterum will test UTI antibiotic again
    FDA said no in July, so Iterum will test UTI antibiotic again

    30 Sep 2021

    // K. LaHucik FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/iterum-will-give-uti-antibiotic-another-go-new-trial-after-meeting-fda

    K. LaHucik FIERCEBIOTECH
    30 Sep 2021
    Share Share